Monday, November 25, 2013 5:55:27 PM
If you worry every time you see a post making a wildly inaccurate claim against the company that is refuted by many resources of the very highest credibility (pubmed, patent offices, etc etc) then maybe reading stock message boards of high tech stocks is not the best approach for you. (There are many other ways of doing due diligence.) SMBs (GOOD oones,that is) can be a good way to find out the current most important details about a company but to do this you MUST be able to sort the wheat from the chaff. There will be some deep insight and highly useful supplemental information on a good board (like this one) but there will be complete rubbish as well.
Every high stock board I've ever been on (many dozens in the last 15 years) has had repeated attacks by posters making flagrantly false claims with no evidence whatsoever to support them and refuted by very strong independent and objective sources.
It's an absolutely inescapable part of using stock message boards. YOu can put all of the objectionable posters on ignore but you will still see the responses to them.
The effective way to deal with such "low quality" posting (to put it exceedingly generously) is to note the counter evidence that promptly appears on a good board such as this one, or to dig up some counter evidence of your own (you should do that at least occasionally for the benefit of the learning experience as well as doing your part to support the board)
It's just like public Junior high schools (in the USA): you have to run the gauntlet of trash talk in the hallways and learn to take it for what it's worth: ZILCH. ZERO. NADA
The rule of perversity in high tech stocks: the better the company does, the more trash talk there is on its boards. Consider it the price of success.
PS you can put posters on "ignore" Click on their screen name and you'll get their profile (as in the example below)
http://investorshub.advfn.com/boards/profilea.aspx?user=60546
on the left side of the page, fourth line below their picture is "ignore this 'member'"
click on it and you won't see their post's anymore.
(on some boards, clicking on several ID's will reduce the number of messages to read by half with no loss of quality at all. (quite the contrary)
Every high stock board I've ever been on (many dozens in the last 15 years) has had repeated attacks by posters making flagrantly false claims with no evidence whatsoever to support them and refuted by very strong independent and objective sources.
It's an absolutely inescapable part of using stock message boards. YOu can put all of the objectionable posters on ignore but you will still see the responses to them.
The effective way to deal with such "low quality" posting (to put it exceedingly generously) is to note the counter evidence that promptly appears on a good board such as this one, or to dig up some counter evidence of your own (you should do that at least occasionally for the benefit of the learning experience as well as doing your part to support the board)
It's just like public Junior high schools (in the USA): you have to run the gauntlet of trash talk in the hallways and learn to take it for what it's worth: ZILCH. ZERO. NADA
The rule of perversity in high tech stocks: the better the company does, the more trash talk there is on its boards. Consider it the price of success.
PS you can put posters on "ignore" Click on their screen name and you'll get their profile (as in the example below)
http://investorshub.advfn.com/boards/profilea.aspx?user=60546
on the left side of the page, fourth line below their picture is "ignore this 'member'"
click on it and you won't see their post's anymore.
(on some boards, clicking on several ID's will reduce the number of messages to read by half with no loss of quality at all. (quite the contrary)
Recent NNVC News
- In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides • ACCESS Newswire • 05/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:01:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:30:33 PM
- NanoViricides Announces Closing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/19/2026 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 12:45:22 PM
- Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides • ACCESS Newswire • 05/18/2026 12:30:00 PM
- NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/15/2026 12:35:00 PM
- NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II • ACCESS Newswire • 05/15/2026 12:00:00 PM
- Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides • ACCESS Newswire • 05/11/2026 12:30:00 PM
- NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference • Newsfile • 05/06/2026 07:37:00 PM
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA • ACCESS Newswire • 05/04/2026 12:30:00 PM
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
